03/04/2024
8:20 PM | Marrazzo Jeffrey D (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:01 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
7:04 AM | Prime Medicine (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/01/2024
7:09 AM | Prime Medicine (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024
3:21 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2023 GP, L.L.C. (Reporting)
GV 2023 GP, L.P. (Reporting)
GV 2023, L.P. (Reporting)
Prime Medicine (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/27/2024
8:35 AM | Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:01 PM | Alenson Carman (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/23/2024
4:03 PM | Duffield Jeremy (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
8:31 PM | ARCH Venture Fund XII, L.P. (Filed by)
Prime Medicine (Subject)
| Form SC 13D | |
02/20/2024
4:37 PM | Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:37 PM | ARCH Venture Fund X Overage, L.P. (Reporting)
ARCH Venture Fund X Overage, L.P. (Reporting)
ARCH Venture Fund X, L.P. (Reporting)
ARCH Venture Fund X, L.P. (Reporting)
ARCH Venture Partners X Overage, L.P. (Reporting)
ARCH Venture Partners X Overage, L.P. (Reporting)
ARCH Venture Partners X, L.P. (Reporting)
ARCH Venture Partners X, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
Burow Kristina (Reporting)
CRANDELL KEITH (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
GILLIS STEVEN (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:38 PM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
Prime Medicine (Issuer)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:41 PM | Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:41 PM | NELSEN ROBERT (Reporting)
NELSEN ROBERT (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
5:23 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
5:17 AM | Prime Medicine (Filer)
| Form 424B5 | |
02/14/2024
8:57 PM | Prime Medicine (Subject)
| Form FWP | |
02/14/2024
4:27 PM | Prime Medicine (Filer)
| Form 424B5 | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Prime Medicine (Subject)
| Form SC 13G/A | |
01/19/2024
3:17 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/19/2024
3:19 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:01 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:03 PM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
7:15 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
7:11 PM | Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
11:15 PM | Prime Medicine (Filer)
| Form EFFECT | |
11/03/2023
4:23 PM | Prime Medicine (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/25/2023
7:15 PM | Liu David R. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:03 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2019 GP, L.L.C. (Reporting)
GV 2019 GP, L.P. (Reporting)
GV 2019, L.P. (Reporting)
GV 2021 GP, L.L.C. (Reporting)
GV 2021 GP, L.P. (Reporting)
GV 2021, L.P. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:17 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2019 GP, L.L.C. (Reporting)
GV 2019 GP, L.P. (Reporting)
GV 2019, L.P. (Reporting)
GV 2021 GP, L.L.C. (Reporting)
GV 2021 GP, L.P. (Reporting)
GV 2021, L.P. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:47 PM | Chung Wendy (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:48 PM | Kelly Michael Aaron (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:49 PM | NELSEN ROBERT (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:49 PM | Foster-Cheek Kaye I (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:50 PM | Prime Medicine (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:51 PM | Cahill Thomas (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:22 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2019 GP, L.L.C. (Reporting)
GV 2019 GP, L.P. (Reporting)
GV 2019, L.P. (Reporting)
GV 2021 GP, L.L.C. (Reporting)
GV 2021 GP, L.P. (Reporting)
GV 2021, L.P. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:20 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2019 GP, L.L.C. (Reporting)
GV 2019 GP, L.P. (Reporting)
GV 2019, L.P. (Reporting)
GV 2021 GP, L.L.C. (Reporting)
GV 2021 GP, L.P. (Reporting)
GV 2021, L.P. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:59 PM | Alphabet Holdings LLC (Reporting)
Prime Medicine (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
4:00 PM | Alphabet Holdings LLC (Reporting)
Prime Medicine (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2023
3:15 PM | Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
05/30/2023
3:48 PM | Alphabet Holdings LLC (Reporting)
Prime Medicine (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2023
4:07 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2019 GP, L.L.C. (Reporting)
GV 2019 GP, L.P. (Reporting)
GV 2019, L.P. (Reporting)
GV 2021 GP, L.L.C. (Reporting)
GV 2021 GP, L.P. (Reporting)
GV 2021, L.P. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:21 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2019 GP, L.L.C. (Reporting)
GV 2019 GP, L.P. (Reporting)
GV 2019, L.P. (Reporting)
GV 2021 GP, L.L.C. (Reporting)
GV 2021 GP, L.P. (Reporting)
GV 2021, L.P. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
3:29 PM | Alphabet Holdings LLC (Reporting)
Prime Medicine (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2023
6:09 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2023
3:16 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2019 GP, L.L.C. (Reporting)
GV 2019 GP, L.P. (Reporting)
GV 2019, L.P. (Reporting)
GV 2021 GP, L.L.C. (Reporting)
GV 2021 GP, L.P. (Reporting)
GV 2021, L.P. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
3:16 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2019 GP, L.L.C. (Reporting)
GV 2019 GP, L.P. (Reporting)
GV 2019, L.P. (Reporting)
GV 2021 GP, L.L.C. (Reporting)
GV 2021 GP, L.P. (Reporting)
GV 2021, L.P. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
7:05 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
7:08 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
7:09 AM | Prime Medicine (Filer)
| Form DEFA14A | |
05/11/2023
7:22 AM | Prime Medicine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2023
4:38 PM | GV 2019, L.P. (Reporting)
Prime Medicine (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/28/2023
7:38 AM | Prime Medicine (Filer)
| Form DEFA14A | |
04/28/2023
7:34 AM | Prime Medicine (Filer)
| Form DEF 14A | |
